Market Access Views & Analysis

Views & Analysis

Market Access

The future of biomedical research is animal-free

Despite the subtle change and lack of immediate impact on patients, the FDA Modernization Act 2.0 is anything but inconsequential, as Pepper Bio's Samantha Dale explains

Market Access

Shaping the path to gender parity in pharma leadership

Thermo Fisher Scientific's Urmi Prasad Richardson explores what still needs to be done to deliver on the promise of gender inclusion and elevate female leadership in business

Market Access

ABPI Annual Conference 2023 – patients, partnerships, and po...

Attending this year’s Association of British Pharmaceutical Industry (ABPI) Conference in London on Thursday 27th April, it quickly became clear that the day would be a notable one – not ju

Market Access

Reaching the prescriber in 2023

For pharma brand teams tasked with achieving engagement with prescribers on in-market products, as well as new treatments in the pipeline, reaching the 2023 prescriber requires a new playbook.

Market Access